论文部分内容阅读
目的观察妥洛特罗贴剂联合布地奈德雾化吸入治疗喘息性支气管炎的临床效果。方法将50例喘息性支气管炎患儿随机分为观察组和对照组各25例,2组均先给予抗感染、扩张支气管治疗2周,2周后观察组采用妥洛特罗贴剂联合布地奈德混悬液雾化吸入治疗;对照组仅使用布地奈德混悬液雾化吸入治疗。结果观察组的咳嗽症状、喘息症状及合并用药的评分均低于对照组,喘息发作的次数和呼吸道感染的次数均少于对照组,差异均有统计学意义(P<0.05)。个别患儿出现了皮肤瘙痒和鹅口疮,均通过治疗得到缓解。2组患儿不良反应发生率差异无统计学意义(P>0.05)。结论妥洛特罗贴剂联合布地奈德雾化吸入治疗婴幼儿喘息性支气管炎有明显临床疗效,具有临床应用价值。
Objective To observe the clinical effect of tulobuterol patch combined with budesonide inhalation for asthmatic bronchitis. Methods Fifty children with asthmatic bronchitis were randomly divided into observation group (25 cases) and control group (25 cases). Both groups were given anti-infection and bronchial expansion for 2 weeks. After 2 weeks, the observation group was treated with tulobuterol patch and budesonide Ned suspension inhalation therapy; control group, only budesonide suspension inhalation therapy. Results The scores of cough, wheezing and combined medication in observation group were lower than those in control group. The number of wheezing episodes and respiratory tract infections in observation group were less than those in control group (P <0.05). Individual children with itchy skin and thrush, were relieved by treatment. There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion The application of tulobuterol and budesonide inhalation in the treatment of infantile asthmatic bronchitis has obvious clinical curative effect and has clinical value.